2022Journal of Pharmaceutical Negative ResultsOpen access

Molecular Docking Of Withaferin A From Withania Somnifera With The Proteins Associated With Cancer Therapy

SIVAKUMAR. G. DEVIBALA

Open full text 2 citations

Abstract

Withaferin-A, a member of the withanolides class, is an essential phytoconstituent of Withania somnifera (Ashwagandha). These are naturally occurring C28-steroidal lactone triterpenoids groupings. For several decades, Withaferin-A was in use for several decade to treat various disorders. Design and development of an effective compound to combat cancer is clearly critical in the current circumstances. Therefore, it is of interest to document the molecular docking analysis data of the different cancer therapy with Withaferin-A from Withania somnifera in the context of cancer for further consideration. Here, we report the optimal interaction features of Withaferin A, different cancer receptors having low binding energies -9.93, -8.34, -9.93, -8.03, -9.69, -6.10 kcal/mol respectively) in this report. In order to gain additional insights, the interaction pattern of compounds with anti- cancer activities was studied.

Open-access reader

About this research paper

What this paper is about

Withaferin-A, a member of the withanolides class, is an essential phytoconstituent of Withania somnifera (Ashwagandha). These are naturally occurring C28-steroidal lactone triterpenoids groupings. For several decades, Withaferin-A was in use for several decade to treat various disorders. Design and development of an effective compound to combat cancer is clearly critical in the current circumstances. Therefore, it is of interest to document the molecular docking analysis data of the different cancer therapy with Withaferin-A from Withania somnifera in the context of cancer for further consideration. Here, we report the optimal interaction features of Withaferin A, different cancer receptors having low binding energies -9.93, -8.34, -9.93, -8.03, -9.69, -6.10 kcal/mol respectively) in this report. In order to gain additional insights, the interaction pattern of compounds with anti- cancer activities was studied.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Withaferin-A, a member of the withanolides class, is an essential phytoconstituent of Withania somnifera (Ashwagandha). These are naturally occurring C28-steroidal lactone triterpenoids groupings. For several decades, Withaferin-A was in use for several decade to treat various disorders. Design and development of an effective compound to combat cancer is clearly critical in the current circumstances. Therefore, it is of interest to document the molecular docking analysis data of the different cancer therapy with Withaferin-A from Withania somnifera in the context of cancer for further consideration. Here, we report the optimal interaction features of Withaferin A, different cancer receptors having low binding energies -9.93, -8.34, -9.93, -8.03, -9.69, -6.10 kcal/mol respectively) in this report. In order to gain additional insights, the interaction pattern of compounds with anti- cancer activities was studied.

Key concepts: Withaferin A, Withania somnifera, Docking (animal), Cancer therapy, Cancer, Context (archaeology), Biology, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Molecular Docking Of Withaferin A From Withania Somnifera With The Proteins Associated With Cancer Therapy — Research Paper | ScholarLens